Most of mankind's innovative new drugs or products started with novel ideas. Although many diseases are being conquered by innovative new drugs, intractable diseases such as cancer, brain disease, and autoimmune disease are still conundrum. In order to conquer intractable diseases that are essential for the high quality of life and life extension of mankind, "OmniaMed" began in December 2019 through the founding of POSTECH Start-up.

OmniaMed's goal is to develop innovative drugs that did not exist until yesterday by developing and utilizing technologies that control nitric oxide, noting that it already exists in the human body, plays a key role in many diseases.

OmniaMed is moving toward the world's best bio companies with the efforts of outstanding researchers through optimized research infrastructure and creative research. We are also doing our best to become a beacon of hope for suffering patients and regain a healthy life through innovative new drug development.

Please leave open the possibility of application to various diseases by developing a new drug specialized for nitrous oxide and give generous love and encouragement to OmniaMed, which is growing not only in Korea but also in the global market.

OmniaMed CEO Won Jong Kim